Pretreatment HIV Drug Resistance and Virologic Outcomes to First-Line Antiretroviral Therapy in Peru

Access to nucleoside reverse transcriptase inhibitor (NRTI) and non-nucleoside reverse transcriptase inhibitor (NNRTI) first-line antiretroviral therapy (ART) for HIV has been increasing in Peru since a national ART program was initiated in 2004. Between 2007 and 2009, we found a 1% prevalence of pr...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:AIDS Res Hum Retroviruses
Auteurs principaux: Soria, Jaime, Mugruza, Raquel, Levine, Molly, León, Segundo R., Arévalo, Jorge, Ticona, Eduardo, Beck, Ingrid A., Frenkel, Lisa M.
Format: Artigo
Langue:Inglês
Publié: Mary Ann Liebert, Inc., publishers 2019
Sujets:
Epidemiology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6360394/
https://ncbi.nlm.nih.gov/pubmed/30560685
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2018.0239
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires